Immediate Impact

1 from Science/Nature 34 standout
Sub-graph 1 of 15

Citing Papers

Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications
2024 Standout
Natural killer cell therapies
2024 StandoutNature
2 intermediate papers

Works of Anuj Patel being referenced

A phase 2 trial of regorafenib as a single agent in patients with chemotherapy‐refractory, advanced, and metastatic biliary tract adenocarcinoma
2018
Molecular Targeted Therapy in Hepatocellular Carcinoma: From Biology to Clinical Practice and Future
2014

Author Peers

Author Last Decade Papers Cites
Anuj Patel 170 175 69 93 25 296
Yuexin Tong 111 106 59 126 34 283
Cole Wh 107 129 16 72 33 298
Andrea Tufo 180 158 25 127 20 299
Tunan Yu 93 123 53 73 27 309
Kazune Fujisawa 104 137 15 146 38 286
Emily E. Van Seventer 199 58 93 80 22 335
Roberto Filippi 184 142 43 92 25 304
Supriya Chopra 169 159 39 87 18 281
Moses S. Raj 159 112 64 58 25 240
Joan Llach 171 179 32 72 19 284

All Works

Loading papers...

Rankless by CCL
2026